Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.

i

Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

Current Public Domain

11/15/2019
By Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.

File Language:

English

Details

Personal Author:

Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.
Corporate Authors:

American Cancer Society
Description:

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well as isoniazid-resistant but rifampin-susceptible TB.
Subjects:

Drug Monitoring Tuberculosis Tuberculosis, MDR Tuberculosis, Multidrug-Resistant
Source:

American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 10,
Document Type:

Journal Article
Genre:

Practice Guideline
Place as Subject:

United States
Pages in Document:

p. 93-142
Volume:

200
Issue:

10
Collection(s):

Guidelines and Recommendations
Main Document Checksum:

urn:sha-512:614450d7a6d879e4ae5b95713a0c7f3e9666103019cd29594a9111a6b1b8f24de9f34e818b61c0529091e875a56887fd73d04180f49f61102cf24fcd72776fa6
Download URL:

https://stacks.cdc.gov/view/cdc/91163/cdc_91163_DS1.pdf
File Type:

[PDF - 1.08 MB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.